LCTX Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Lineage Cell Therapeutics Inc (LCTX) Moving Averages Convergence Divergence (MACD) indicator is 0.0273, suggesting LCTX is Neutral.

Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 1.816, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it Sell.

Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.724, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it Sell.

Technical Analysis for LCTX

Technical Sentiment Analysis for Lineage Cell Therapeutics Inc (LCTX) As of 2026-03-11, Lineage Cell Therapeutics Inc (LCTX) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 6 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for LCTX stands at 45.754, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0273, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 26.693 and the Commodity Channel Index (CCI) at -71.873 further confirm a -0.17 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, LCTX is trading above its 60-day moving average of $1.724 and above its 200-day long-term moving average of $1.439. Key price levels to watch include the immediate resistance at $1.996 and strong support at $1.726. A break above $1.996 could signal a bull continuation, while falling below $1.726 may test the next Fibonacci floor at $1.586.

Lineage Cell Therapeutics Inc (LCTX) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.456	1.586	1.726	1.856	1.996	2.126	2.266
Fibonacci	1.586	1.689	1.753	1.856	1.959	2.023	2.126

Lineage Cell Therapeutics Inc (LCTX) Technical Indicators

2026-03-11

Name	Value
RSI_14	45.754
STOCHk_14_3_3	26.693
STOCHd_14_3_3	41.639
CCI_20	-71.873
AO_5_34	0.0827
MOM_10	-0.17
MACD_12_26_9	0.0273

Lineage Cell Therapeutics Inc (LCTX) Relative Strength Index (RSI) is 45.754, creating a Neutral signal.

Lineage Cell Therapeutics Inc (LCTX) Stochastic Oscillator is 26.693, creating a Neutral signal.

Lineage Cell Therapeutics Inc (LCTX) Stochastic RSI is 41.639, creating a Neutral signal.

Lineage Cell Therapeutics Inc (LCTX) Commodity Channel Index (CCI) is -71.873, creating a Neutral signal.

Lineage Cell Therapeutics Inc (LCTX) Awesome Oscillator is 0.0827, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Momentum is -0.17, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) MACD is 0.0273, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Moving Average

2026-03-11

Period	Simple	Signal
MA_5	1.8	Sell
MA_10	1.867	Sell
MA_20	1.816	Sell
MA_60	1.724	Sell
MA_200	1.439	Buy
MA_250	1.245	Buy

Lineage Cell Therapeutics Inc (LCTX) 5-Day simple moving average is 1.8, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 10-Day simple moving average is 1.867, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 1.816, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.724, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 200-Day simple moving average is 1.439, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it a Buy.

Lineage Cell Therapeutics Inc (LCTX) 250-Day simple moving average is 1.245, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.715, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for LCTX?

The overall technical consensus for Lineage Cell Therapeutics Inc (LCTX) is currently Neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 3 sell signals.

What are the key support and resistance levels for Lineage Cell Therapeutics Inc (LCTX) today?

Based on pivot point calculations, Lineage Cell Therapeutics Inc (LCTX) has an immediate support level at 1.726 and a major resistance level at 1.996. Traders also monitor the pivot point at 1.856 to determine the intraday trend direction.

Is Lineage Cell Therapeutics Inc (LCTX) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Lineage Cell Therapeutics Inc (LCTX) is currently 45.754. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Lineage Cell Therapeutics Inc (LCTX)?

Lineage Cell Therapeutics Inc (LCTX) Moving Averages Convergence Divergence (MACD) indicator is 0.0273, suggesting LCTX is Neutral. This indicator helps identify potential trend reversals or momentum shifts for Lineage Cell Therapeutics Inc.

How is Lineage Cell Therapeutics Inc (LCTX) performing relative to its 200-day moving average?

Lineage Cell Therapeutics Inc (LCTX) is currently trading at $1.715, which is above its 200-day simple moving average of 1.439. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.